We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$89.8B
AUM Growth
+$11.9B
Cap. Flow
-$2.77B
Cap. Flow %
-3.09%
Top 10 Hldgs %
9.11%
Holding
2,631
New
147
Increased
1,215
Reduced
1,097
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 18.8%
2 Industrials 13.1%
3 Financials 12%
4 Healthcare 11.59%
5 Consumer Discretionary 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RES icon
2426
RPC Inc
RES
$1.3B
$49K ﹤0.01%
15,492
+3,523
+29% +$10.6K
TXMD icon
2427
TherapeuticsMD
TXMD
$24M
$49K ﹤0.01%
814
+130
+19% +$8.88K
AUD
2428
DELISTED
Audacy, Inc.
AUD
$47K ﹤0.01%
19,186
+977
+5% +$2K
OCGN icon
2429
Ocugen
OCGN
$434M
$46K ﹤0.01%
25,243
+5,712
+29% +$2.75K
XXII
2430
22nd Century Group
XXII
$1.48M
0
LTRPA
2431
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$46K ﹤0.01%
10,518
-143,354
-93% -$388K
AMPE
2432
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$46K ﹤0.01%
97
+10
+11% +$3.28K
TELL
2433
DELISTED
Tellurian Inc.
TELL
$45K ﹤0.01%
35,431
+3,133
+10% +$3.54K
LITS
2434
Lite Strategy Inc
LITS
$30.9M
$43K ﹤0.01%
820
+95
+13% +$5.48K
PDLI
2435
DELISTED
PDL BioPharma, Inc.
PDLI
$43K ﹤0.01%
17,605
-202,912
-92% -$494K
LCTX icon
2436
Lineage Cell Therapeutics
LCTX
$278M
$42K ﹤0.01%
24,122
+1,233
+5% +$1.72K
LXRX icon
2437
Lexicon Pharmaceuticals
LXRX
$1.1B
$42K ﹤0.01%
+12,326
New +$23.5K
RNAC icon
2438
Cartesian Therapeutics
RNAC
$268M
$41K ﹤0.01%
452
-19
-4% -$1.65K
NBEV
2439
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$41K ﹤0.01%
15,514
+911
+6% +$2.48K
ANH
2440
DELISTED
Anworth Mortgage Asset Corporation
ANH
$41K ﹤0.01%
15,128
+787
+5% +$1.63K
FBIO icon
2441
Fortress Biotech
FBIO
$88.7M
$39K ﹤0.01%
827
+100
+14% +$4.33K
NEXT icon
2442
NextDecade
NEXT
$1.78B
$39K ﹤0.01%
18,574
+928
+5% +$2.35K
CASI
2443
DELISTED
CASI Pharmaceuticals
CASI
$37K ﹤0.01%
1,246
+202
+19% +$4.39K
YARW
2444
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$36K ﹤0.01%
6
CTIC
2445
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$36K ﹤0.01%
11,120
+573
+5% +$1.91K
GSAT icon
2446
Globalstar
GSAT
$10.8B
$35K ﹤0.01%
6,903
+353
+5% +$1.71K
WTI icon
2447
W&T Offshore
WTI
$518M
$34K ﹤0.01%
15,676
+811
+5% +$1.56K
BKCC
2448
DELISTED
BlackRock Capital Investment Corporation
BKCC
$33K ﹤0.01%
12,114
+632
+6% +$1.7K
MCF
2449
DELISTED
Contango Oil & Gas Co.
MCF
$33K ﹤0.01%
14,428
+2,162
+18% +$3.56K
AVTX icon
2450
Avalo Therapeutics
AVTX
$983M
$32K ﹤0.01%
4

Similar funds

Victory Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Victory Capital Management held 2,631 positions worth $89.8B, up 15% from $77.9B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Victory Capital Management withdrew a net $2.77B in Q4 2020, closing 95 positions and reducing 1,097 holdings. Its most notable exit was iShares MSCI EAFE Min Vol Factor ETF, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Victory Capital Management opened a new position in iShares 7-10 Year Treasury Bond ETF worth $61M.

  • Victory Capital Management's largest Q4 2020 buy was iShares 7-10 Year Treasury Bond ETF: 508,358 shares worth $61M.
  • Victory Capital Management added most to Victory Portfolios II VictoryShares Core Intermediate Bond ETF in Q4 2020, an estimated $169M increase.
  • Victory Capital Management's biggest Q4 2020 reduction was Public Storage, cutting an estimated $180M.
  • Victory Capital Management fully exited iShares MSCI EAFE Min Vol Factor ETF in Q4 2020, selling an estimated $121M.
  • Victory Capital Management's ten largest holdings make up 9.1% of its $89.8B portfolio in Q4 2020.
  • Victory Capital Management opened 147 new positions and closed 95 in Q4 2020.
  • Victory Capital Management's portfolio value rose 15% quarter-over-quarter to $89.8B.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.